ArticleThe journal of liquid biopsy2026

A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.

Cong Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.